• Cash receipts of $1m, up 22% on the pcp
• Operating cash outflow of $0.3m, improved from $0.5m outflow in the pcp
• Annual Recurring Revenue of $1.95m at the end of Q2 FY26, up 23% on the pcp

Visionflex Group Limited (ASX:VFX), a leader in virtual healthcare technology, has provided its Appendix 4C and quarterly market update for the 3 months ending 31 December 2025. The company reported cash receipts of $1 million, up 22% on the prior corresponding period (pcp). The operating cash outflow was $0.3 million, an improvement from the $0.5 million outflow in the pcp, driven by tighter cost control and a higher proportion of recurring revenue. Unaudited revenue was $0.8 million, down 12% on the pcp, with approximately 55% of quarterly revenue being recurring. Annual Recurring Revenue (ARR) was $1.95 million, up 23% on the pcp. Excluding the conclusion of the Siemens' three-year trial, ARR would have increased 31% on pcp and 6% on Q1 FY26, reflecting underlying growth across the core customer base. The company also highlighted progress across key enterprise and government customers, including the renewal of the Royal Flying Doctor Service (RFDS) Victoria contract for a second year and continued deployments with Amplar Health (Medibank).

Visionflex remains focused on expanding its recurring revenue base, supported by increasing customer engagement across aged care, regional healthcare, and complex service delivery environments. This momentum is being reinforced by the company's strategic focus aimed at accelerating ARR growth and deepening enterprise and government relationships.

Visionflex continues to progress strategic partnerships designed to enhance integration, support scale, and drive broader adoption of its software platform. Collectively, these initiatives are expected to contribute to revenue growth in H2 FY26.